MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2018 International Congress

    Pupillary autonomic dysfunction and oculomotor characteristics of multiple system atrophy

    K.W. Park, EJ. Lee, N.R. Choi, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

    Objective: To investigate the pupillary autonomic function and oculomotor characteristics of patients with multiple system atrophy (MSA). Background: MSA is a debilitating neurodegenerative disorder with…
  • 2018 International Congress

    Postural deformities in Chinese patients with multiple system atrophy

    L. Zhang, B. Cao, Y. Zou, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shanng (Chengdu, China)

    Objective: The objective of our study was to investigate the frequency and clinical characteristics of the postural deformities in Chinese patients with multiple system atrophy…
  • 2018 International Congress

    Unusual prolonged survival in multiple system atrophy: A case report

    DM. Giraldo, A. Garrido, C. Simonet, J. Saavedra, Y. Compta, M. Marti, E. Tolosa, F. Valldeoriola (Barcelona, Spain)

    Objective: To present a case of a patient with multiple system atrophy (MSA) parkinsonian subtype (MSA-P) with unusual long disease duration. Background: MSA is a…
  • 2018 International Congress

    Utility of Acute Levodopa Challenge Test In Early Parkinsonism

    M. Acharya, A. Biswas, G. Ganguly, S. Das (Kolkata, India)

    Objective: This prospective cohort study was conducted to evaluate the sensitivity and specificity of different outcomes of acute levodopa challenge test(ALCT) (motor improvement, development of…
  • 2018 International Congress

    Patient Perspective in Multiple System Atrophy

    A. Mahajan, Z. Mari (Detroit, MI, USA)

    Objective: To report patient and/ or caregiver perspective in Multiple System Atrophy (MSA). Background: The majority of literature on MSA’s natural history comes from single…
  • 2017 International Congress

    Cerebrospinal Fluid Levels of Coenzyme Q10 are Reduced in Multiple System Atrophy

    Y. Compta, F. Antonelli, M. Fernandez, P. Bravo, M. Soto, A. Camara, D.M. Giraldo, M.J. Marti, On-behalf-of Catalan-MSA-Registry Group (Barcelona, Spain)

    Objective: To assess CSF levels of coenzyme Q10 in multiple system atrophy (MSA) vs. Parkinson’s disease (PD), progressive supranuclear palsy (PSP), and control subjects without…
  • 2017 International Congress

    Semi-automated MRI algorithm using susceptibility weighted imaging for differentiating multiple system atrophy with parkinsonism from Parkinson Disease

    W.-W. Lee, H.-J. Kim, C.-H. Sohn, H. Park, B. Jeon (Seoul, Republic of Korea)

    Objective: To investigate the diagnostic value of semi-automated diagnostic algorithm using 3T-MR susceptibility-weighted image (SWI) for multiple system atrophy with parkinsonism (MSA-p). Background: Iron deposition…
  • 2017 International Congress

    The predictor factors for survival in Chinese Multiple System Atrophy patients

    B. Cao, L. Zhang, Y. Zou, Q. Wei, R. Ou, Y. Chen, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: Our aim was to explore the predictors of survival in Chinese multiple system atrophy (MSA) patients. Background: MSA is a rare, fatal neurodegenerative disorder with…
  • 2017 International Congress

    Presence of abnormalities on structural MRI associate with faster disease progression in multiple system atrophy

    K. Seppi, F. Krismer, G. Wenning, S. Papapetropoulos, V. Abler, W. Poewe (Innsbruck, Austria)

    Objective: To identify MRI markers that are associated with more rapid clinical progression in multiple system atrophy (MSA) Background: The rate of clinical progression in…
  • 2017 International Congress

    Depression, anxiety and quality of life in Multiple System Atrophy

    L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley